$ME->Wakeup('2021-02-15 00:00:00');
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
About 8m public shares out there, limited supply!
Latest 10K:
https://www.sec.gov/Archives/edgar/data/1069308/000156459020011639/acer-10k_20191231.htm
As of March 1, 2020, 10,095,176 shares of the registrant’s common stock, were outstanding. 150,000,000 shares Authorized but not issued.
As of March 1, 2020, our executive officers and directors and their affiliates beneficially owned or controlled approximately 19% of the outstanding shares of our common stock.
Get 'em while you can!
Best,
JB
I feel its RLF's vehicle to get listed on the NASDAQ... Count me in, I strongly feel it will run
Best,
JB
TODAY it awoke... hold tight
Great post!
This will run more than that, I have "friends" coming
Get in while you can, big things coming
Correct, they would increase significantly upon merger to more closely align with share price. Considering I own some of both BRPAW & BRPAR, I am betting on it going through for a higher % increase than the shares I own as well. They will be long term holds for me.
Best,
JB
BRPAW & BRPAR are undervalued due to an amount of risk associated with them. If there is no merger that would mean they have no value while the shares are covered by funds in the trust.
Best,
JB
Well you will not be calling the US Government COVID19 Task Force or whatever they decide to call the new group of people assembled by the US government to battle COVID19 Operation Warp Speed anymore, so yes OWS is effectively gone. I now remember the old saying to "never argue with ....". mehhh forget it, lets move on.
Best,
JB
FUD attempt again.... "existing" meant the SSF that was in place at that time. OWS aka "BigPharma ATM" has been mothballed, you might have heard that there is now a new administration leading the US government. We will need some cash to make the drug and expand...
Sheesh,
JB
"You must spend money to make money."
- Plautus
RLF wants some dry powder, GEM agreed to give them a 50m line of credit for 90% of market share price. GEM sees the shares as valuable much like Advita did... Both of those companies know RLF shares will be extremely valuable and scarce when completed trial results are released in the next few weeks as everyone will be holding.
Wanting AND Having access to 50m capital "if needed" is a good thing, we are about to save the world.
Best,
JB
People buying the rumor... hold tight!
Also, I think it might take a few days for data analysis
Best,
JB
Patience is a virtue
Since you have been civil lately, I'll respond. I do not think any corporate action on structure change will occur prior to RCT data or any other material event. I think they let the share price ride out after the events and see where they are at. "Near term" means within this year to me as opposed to long term. Anything other than that is guessing but I'm sure no matter what will be too long for you :)
Best,
JB
I would be one of those who disagrees with you, heres why; RLF just included an "about" in their PR for a SPAC their "partner" is merging with. It is a extremely odd to do this for your "partner". In addition, remember the slide we just saw from Relief and what it said on the bottom about uplist? Look at the closing sentence on that about section from the PR:
"ABOUT BIG ROCK PARTNERS ACQUISITION CORP.
Big Rock Partners Acquisition Corp. is a blank check company formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. Big Rock’s management team includes Richard Ackerman, Chairman, President, and Chief Executive Officer, and Bennett Kim, Chief Financial Officer, Chief Investment Officer, Corporate Secretary and Director. Big Rock’s common stock, units, rights and warrants are quoted on the Nasdaq Capital Market under the ticker symbols BRPA, BRPAU, BRPAR and BRPAW, respectively."
It was followed by a tremendous amount of CYA language and subsequently more than 1/2 the PR was devoted to NRX/BRPA... I don't know how much clearer it could be honestly.
near-term,
JB
There has only been good news and it seems more is on the way. Ignore the daily noise from Trolls who spread FUD(Fear,Uncertainty,Doubt). They have an agenda and it is certainly is not to protect YOUR investment. Investments unlike lottery tickets take time to mature. If the company does a RS or if they merge with NRX does it really matter? Approval is basically a given imo as well as the amount of my investment increasing dramatically. Just relax, enjoy life and dont worry about insignificant events or speculation about non events. Think big picture, be an investor...
Credit to Whino
https://file.io/3CMPqe3EI8eV
Best,
JB
We filed for an EUA based off EAP patient data, were not denied but rather informed the FDA would like additional data. Specifically, the results from the randomized controlled trial. The EUA could be granted immediately upon FDA review of this additional data, there is no "reapplication" etc since we were not denied.
Best,
JB
Wow... Now think about what we knew in about VIP in August compared to now. Who wouldnt want in?!?!
No other has results like this. Have you seen the diagnostic imaging and chart data for the EAP patients? NOONE has that...Lungs clearing and O2 levels improving significantly on unconscious intubated patients and now even non covid double lung transplant candidates!
**MC HAMMER DANCE**
"CAN,'T TOUCH THIS"
It's a golden, once in a lifetime opportunity imo...
-JB
People think safe and effective treatment for a global pandemic might be a good investment? ¯\_(?)_/¯
I follow afirebrand on /r, amazingly good posts. Tons of sourced information and quality in each and every one. Always a good read.
Best,
JB
Recieved 6 doses of IV followed by daily inhaled. She was COVIDA free at the time and suffering from after affects. The FDA signed off on this as her condition and treatment regimen is unlike any other in the patient in trial or that has received under EAP.
THIS is what should get people excited. Not only will it help with the current global pandemic, how about EVERY OTHER LUNG AILMENT TOO!!!
I have my winning lottery tickets, they will only increase in value.
"Our favorite holding period is forever"
-Warren Buffett
Best,
-JB
Effective treatment for COVID and ARDS is priceless
"Oh but theres sooo many shares" More than half of the outstanding shares are held by insiders, so the public float is about 1.5B. News will be coming...
Best,
JB
On the same sentiment, GEMs ownership percentage dropping below 50% is legally required to be reported... They haven't said or released anything. AND if they did, wouldn't matter to me as I am not fond of wearing a tinfoil hat.
Keep off the caps,
-JB
NO... If GEM dropped below 50% it would have to be reported to SIX and we would know. Looking for new material eh? Try again....
FFS,
JB
The difference is with this being an OTC you have speculative inpatient "traders" involved with the RLFTF public float.
A "investor" looks at the company, its products and says "This looks pretty good and will be worth significantly more than I paid for it at some point"... such is the case with RLFTF.
Obsessing over RLFTF daily price, L2 info and "No PR in a week" will drive you mad and is NOT what an investor does. It has been a interesting learning experience for me to even see this first hand, 6 months of holding a ticker is just a "blip" of time in my opinion.
Nothing has changed other than a steady stream of positive news. I havent heard any negative news... The pace of which has increased as well. Ignore the daily noise, you did your DD -- your investment will take care of itself. Enjoy time with friends and family ... Be a investor
Best,
JB
COVID FREE, DOUBLE LUNG TRANSPLANT CANDIDATE NOW OFF ECMO & RECOVERING DUE TO NEW DRUG! AVIPTADIL SAVES LIVES!!!
THIS IS ONLY THE BEGINNING....
DRINKS ON ME,
-JB
RLF management is not your typical OTC pumping style that many seem to yearn for. They partnered with titans of industry to sheperd their drug through the grueling FDA process. The results of the RCT will speak for themselves, volatility will be non existent once data is released as the share price will only increase dramatically. You do you though, I will see you in the rear view mirror... Keep this post for posterity since you are claiming "what you knew from day one" and we can all see just how right you were
Fantastic Post, FKN 75% !!!
Sht like that makes you start doing things like approving to give to a double lung transplant candidate. A COVID longhauler that was already negative for COVID prior to the 1st administration of 6 IV doses RLF-100 (twice the normal course) and then followed up by the inhaled version. The FDA approved THAT and signed off on THAT. I'm holding for a LOOONG time!
https://m.facebook.com/groups/378123663358743/
PRAYERS FOR DELINDA
Best,
JB
Issuing public statements inferring results about an "almost" completed blinded study is not looked upon favorably by the FDA. Could be the basis for severe penalties and other action if the company just winged it. There are set rules, standards and decorum which deviating from could jeopardize everything they have worked this far for. Each day is one closer, hold tight
Completion of a proper study is imperative. You don't do a job 99%, the FDA doesnt care about the stock price. Investors have patience, just relax... It is coming in due time
Best,
JB
Happy New Year
There is no other COVID therapuetic with the safety and efficacy of RLF-100 despite some stoking fear and promoting them as such.
Best,
JB
Over 300 is a completely accurate statement
Not all of the RCT patients recieved the drug, some recieved placebo. So if you add the EAP + the non placebo RCT patients you would get the "over 300" as to how many were treated.
Ignore the nonstop FUD posts, the data is coming soon. Its actually a great time to buy.
Best,
JB
RLF-100 is the only therapeutic that has shown real data to demonstrate its efficacy. Diagnostic imaging showing lung improvement and clinical 02 saturation levels improvement. The RCT results will speak for themselves.
The FDA wants the RCT data, EAP data is supporting documentation. EAP data is more than anecdotal but not gold standard. At the very least, it can calm the FUD purveyors.
Best,
JB
Nothing has changed other than we are now certain that the FDA wants to see the full trial results rather than just the preliminary EAP data to grant an EUA. There was no denial, we would have to reapply if there was. RLF was told that the FDA would like to see the results of the trial. Safety & Efficacy are undeniable based on what have seen already with EAP data. There is a exponentially increasing amount of EAP patients, that data might get to us soon. All is well, ignore the "noise" and have patience.
Best,
JB
Well Username checks out
Before spreading FUD, try to stay away from quotes(It's too easy to refute by just showing the facts :). So here is what was ACTUALLY in the PR:
" Further, Relief has not directly had any discussions with Operation Warp Speed or any other U.S. government agency."
Notice the use of the word DIRECTLY and that U.S. is present before government agency. These are significant and were put there for a reason...
https://relieftherapeutics.com/newsblog/relief-announces-results-of-extraordinary-general-meeting-of-relief-therapeutics-holding-ag-approved-with-large-majority
FknClown,
JB